EP1499343A4 - A method of modulating cellular activity - Google Patents

A method of modulating cellular activity

Info

Publication number: EP1499343A4
Authority: EP; European Patent Office
Prior art keywords: cellular activity; modulating cellular; modulating; activity; cellular
Prior art date: 2002-03-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP03745226A

Other languages

German (de)

French (fr)

Other versions

EP1499343A1 (en

Inventor

Stuart M Pitson

Pu Xia

Paul A Moretti

Julia R Zebol

Mathew A Vadas

Brian W Wattenberg

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Medvet Science Pty Ltd

Original Assignee

Medvet Science Pty Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-28

Filing date

2003-03-28

Publication date

2005-12-28

2002-03-28 Priority claimed from AUPS1448A external-priority patent/AUPS144802A0/en

2002-04-05 Priority claimed from AUPS1538A external-priority patent/AUPS153802A0/en

2002-04-08 Priority claimed from AUPS1621A external-priority patent/AUPS162102A0/en

2002-09-19 Priority claimed from AU2002951668A external-priority patent/AU2002951668A0/en

2003-01-21 Priority claimed from AU2003900230A external-priority patent/AU2003900230A0/en

2003-03-28 Application filed by Medvet Science Pty Ltd filed Critical Medvet Science Pty Ltd

2005-01-26 Publication of EP1499343A1 publication Critical patent/EP1499343A1/en

2005-12-28 Publication of EP1499343A4 publication Critical patent/EP1499343A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Immunology (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Transplantation (AREA)
Genetics & Genomics (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Biochemistry (AREA)
Physical Education & Sports Medicine (AREA)
Biophysics (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Enzymes And Modification Thereof (AREA)

EP03745226A 2002-03-28 2003-03-28 A method of modulating cellular activity Withdrawn EP1499343A4 (en)

Applications Claiming Priority (11)

Application Number	Priority Date	Filing Date	Title
AUPS1448A AUPS144802A0 (en)	2002-03-28	2002-03-28	A method of modulating cellular activity
AUPS144802		2002-03-28
AUPS1538A AUPS153802A0 (en)	2002-04-05	2002-04-05	A method of modulating cellular activity - ii
AUPS153802		2002-04-05
AUPS1621A AUPS162102A0 (en)	2002-04-08	2002-04-08	A method of modulating cellular activity - III
AUPS162102		2002-04-08
AU2002951668		2002-09-19
AU2002951668A AU2002951668A0 (en)	2002-09-19	2002-09-19	A method of modulating cellular activity- IV"
AU2003900230A AU2003900230A0 (en)	2003-01-21	2003-01-21	"A method of modulating cellular activity - V"
AU2003900230		2003-01-21
PCT/AU2003/000388 WO2003082322A1 (en)	2002-03-28	2003-03-28	A method of modulating cellular activity

Publications (2)

Publication Number	Publication Date
EP1499343A1 EP1499343A1 (en)	2005-01-26
EP1499343A4 true EP1499343A4 (en)	2005-12-28

Family

ID=28679096

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP03745226A Withdrawn EP1499343A4 (en)	2002-03-28	2003-03-28	A method of modulating cellular activity

Country Status (5)

Country	Link
EP (1)	EP1499343A4 (en)
JP (1)	JP2005526809A (en)
AU (2)	AU2003215426A1 (en)
CA (1)	CA2480661A1 (en)
WO (1)	WO2003082322A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2005253643B2 (en) *	2004-06-15	2011-12-01	Medvet Science Pty. Ltd.	Methods of modulating cellular activity involving sphingosine kinase and agents for same, and sphingosine kinase variants
JP2008502604A (en) *	2004-06-15	2008-01-31	メドベットサイエンスピーティーワイ．リミティッド	Methods for modulating cellular activity, including sphingosine kinase, substances for modulating, and sphingosine kinase variants
US8324237B2 (en) *	2005-05-20	2012-12-04	Smith Charles D	Methods for the treatment and prevention of inflammatory diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1978097A1 (en) *	1993-07-20	2008-10-08	The Regents of the University of California	Regulation of transcription factor, NF-IL6/LAP
AUPO900297A0 (en) *	1997-09-08	1997-10-02	Medvet Science Pty. Ltd.	A method of modulating cellular activity
CA2280675A1 (en) *	1998-08-26	2000-02-26	Nehama I. Smorodinsky	Enhanced phosphorylation of p53 by atm in response to dna damage
DK1192247T3 (en) *	1999-05-13	2006-07-31	Johnson & Johnson Pharm Res	Sphingosine kinase enzyme
AU765983B2 (en) *	1999-05-28	2003-10-09	Apoptosis Technology, Inc.	Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis
WO2001062288A1 (en) *	2000-02-25	2001-08-30	The Regents Of The University Of California	Membrane estrogen receptor-directed therapy in breast cancer
AUPQ744700A0 (en) *	2000-05-11	2000-06-01	Medvet Science Pty. Ltd.	A method of treatment and agents useful for same
WO2002098458A1 (en) *	2001-06-07	2002-12-12	Medvet Science Pty Ltd	Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity

2003
- 2003-03-28 AU AU2003215426A patent/AU2003215426A1/en not_active Abandoned
- 2003-03-28 JP JP2003579859A patent/JP2005526809A/en active Pending
- 2003-03-28 EP EP03745226A patent/EP1499343A4/en not_active Withdrawn
- 2003-03-28 CA CA002480661A patent/CA2480661A1/en not_active Abandoned
- 2003-03-28 WO PCT/AU2003/000388 patent/WO2003082322A1/en active Application Filing
2009
- 2009-04-24 AU AU2009201639A patent/AU2009201639A1/en not_active Abandoned

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number	Publication date
AU2003215426A1 (en)	2003-10-13
WO2003082322A1 (en)	2003-10-09
AU2009201639A1 (en)	2009-05-21
JP2005526809A (en)	2005-09-08
EP1499343A1 (en)	2005-01-26
CA2480661A1 (en)	2003-10-09

Publication	Publication Date	Title
AU2002367739A1 (en)	2003-09-16	Activity management method
GB2386510B (en)	2004-09-22	Method of automatically altering the behaviour of a wireless information device
GB0303626D0 (en)	2003-03-19	Provision of information regarding a mobile station
GB2389179B (en)	2005-05-25	A method of electrophoresis
EP1577280A4 (en)	2006-08-23	Method of deuterization
AU2003217416A1 (en)	2003-10-20	Method for extending the coverage area of a wireless communication
AU2003297700A8 (en)	2004-06-30	Methods for modulating ikkalpha activity
GB0319361D0 (en)	2003-09-17	A method of and system for wireless communication
EP1488046A4 (en)	2005-11-23	Method of construction
EP1512783A4 (en)	2010-04-07	Method of knitting knit-wear
EP1499343A4 (en)	2005-12-28	A method of modulating cellular activity
GB2405555B (en)	2006-02-22	A cellular communication system and method of operation therefor
AU2002951253A0 (en)	2002-09-19	A method of modulating cellular activity
GB2389252B (en)	2006-09-27	A frequency modulation system & method
GB2408654B (en)	2006-01-11	A cellular communication system and a method of operation therefor
AUPS144802A0 (en)	2002-05-09	A method of modulating cellular activity
AU2002258036A8 (en)	2003-10-27	A method of making salt
AU2003264183A8 (en)	2004-04-19	A method of modulating cellular development
GB0204227D0 (en)	2002-04-10	Modulation of pde11a activity
AUPS153802A0 (en)	2002-05-09	A method of modulating cellular activity - ii
AUPS162102A0 (en)	2002-05-16	A method of modulating cellular activity - III
AU2002951212A0 (en)	2002-09-19	A method of modulating cellular activity and molecules for use therein
GB0219170D0 (en)	2002-09-25	Wireless communication system and a method of operating a wireless communication system
AU2004903249A0 (en)	2004-07-01	A method of modulating cellular activity and agents useful for same
GB2408431B (en)	2006-05-17	A wireless communication system and a method of operating a wireless communication system

Legal Events

Date	Code	Title	Description
2004-12-10	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2005-01-26	17P	Request for examination filed	Effective date: 20041028
2005-01-26	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
2005-01-26	AX	Request for extension of the european patent	Extension state: AL LT LV MK
2005-07-13	RIN1	Information on inventor provided before grant (corrected)	Inventor name: WATTENBERG, BRIAN W. Inventor name: VADAS, MATHEW A. Inventor name: ZEBOL, JULIA R. Inventor name: MORETTI, PAUL, A. Inventor name: XIA, PU Inventor name: PITSON, STUART M.
2005-12-28	A4	Supplementary search report drawn up and despatched	Effective date: 20051110
2007-12-19	17Q	First examination report despatched	Effective date: 20071116
2011-02-25	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2011-03-30	18D	Application deemed to be withdrawn	Effective date: 20101001